{"transactions":[{"id":1915596,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":114285,"kind":"person","name":"Reali Kenneth Michael","position":1,"cik":"0001480801","reported_name":"Reali Kenneth Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Fmr. CEO and Director"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-21T21:19:31.000Z","date":"2022-03-14","kind":"grant","planned":false,"acquired":true,"shares":466054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in four approximately equal installments on each of the first four anniversaries of March 14, 2022, in each case subject to the Reporting Person continuing in service through the applicable vesting date."}],"balance_after":466054,"derivative":{"exercise_price":1.16,"expiration_date":"2032-03-13","underlying":"Class A Common Stock","underlying_shares":466054},"source":{"system":"sec-edgar","filing":"0001578563-23-000024","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000157856323000024/primary_doc.xml","form_type":"4/A","original_submission_date":"2023-03-16"}},{"id":1950040,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":114285,"kind":"person","name":"Reali Kenneth Michael","position":1,"cik":"0001480801","reported_name":"Reali Kenneth Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-17T01:19:47.000Z","date":"2023-03-14","kind":"exercise","acquired":false,"shares":28721,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The original grant of 114,882 RSUs vest in four approximately equal annual installments beginning on March 14, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The original grant of 114,882 RSUs vest in four approximately equal annual installments beginning on March 14, 2023."}],"balance_after":86161,"derivative":{"underlying":"Class A Common Stock","underlying_shares":28721},"source":{"system":"sec-edgar","filing":"0000899243-23-008792","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924323008792/doc4.xml","form_type":"4"}},{"id":1950039,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":114285,"kind":"person","name":"Reali Kenneth Michael","position":1,"cik":"0001480801","reported_name":"Reali Kenneth Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-17T01:19:47.000Z","date":"2022-03-14","kind":"grant","acquired":true,"shares":114882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The original grant of 114,882 RSUs vest in four approximately equal annual installments beginning on March 14, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The original grant of 114,882 RSUs vest in four approximately equal annual installments beginning on March 14, 2023."}],"balance_after":114882,"derivative":{"underlying":"Class A Common Stock","underlying_shares":114882},"source":{"system":"sec-edgar","filing":"0000899243-23-008792","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924323008792/doc4.xml","form_type":"4"}},{"id":1950038,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":114285,"kind":"person","name":"Reali Kenneth Michael","position":1,"cik":"0001480801","reported_name":"Reali Kenneth Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-17T01:19:47.000Z","date":"2023-03-15","kind":"sale","acquired":false,"shares":9811,"price":1.3887,"value":13624.5357,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects shares sold to cover taxes upon the vesting of the RSUs on March 14, 2023 pursuant to a standing 10b5-1 instruction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions ranging from $1.37 to $1.43, inclusive.  Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":30085,"source":{"system":"sec-edgar","filing":"0000899243-23-008792","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924323008792/doc4.xml","form_type":"4"}},{"id":1950037,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":114285,"kind":"person","name":"Reali Kenneth Michael","position":1,"cik":"0001480801","reported_name":"Reali Kenneth Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-17T01:19:47.000Z","date":"2023-03-14","kind":"exercise","acquired":true,"shares":28721,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Class A common stock."}],"balance_after":39896,"source":{"system":"sec-edgar","filing":"0000899243-23-008792","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924323008792/doc4.xml","form_type":"4"}},{"id":2573217,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":114285,"kind":"person","name":"Reali Kenneth Michael","position":1,"cik":"0001480801","reported_name":"Reali Kenneth Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2021-09-10T13:22:25.000Z","date":"2021-09-09","kind":"purchase","acquired":true,"shares":1800,"price":14.81,"value":26658.0,"ownership":{"direct":true},"balance_after":11175,"source":{"system":"sec-edgar","filing":"0000899243-21-035518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924321035518/doc4.xml","form_type":"4"}},{"id":2757922,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":114285,"kind":"person","name":"Reali Kenneth Michael","position":1,"cik":"0001480801","reported_name":"Reali Kenneth Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2021-04-05T20:31:39.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in four equal annual installments beginning on April 1, 2022."}],"balance_after":30000,"derivative":{"exercise_price":15.23,"expiration_date":"2031-03-31","underlying":"Class A Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-21-014831","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924321014831/doc4.xml","form_type":"4"}},{"id":2757921,"issuer":{"id":4996,"kind":"organization","name":"Bioventus Inc."},"owners":[{"id":114285,"kind":"person","name":"Reali Kenneth Michael","position":1,"cik":"0001480801","reported_name":"Reali Kenneth Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-05T20:31:39.000Z","date":"2021-02-11","kind":"purchase","acquired":true,"shares":9375,"price":13,"value":121875.0,"ownership":{"direct":true},"balance_after":9375,"source":{"system":"sec-edgar","filing":"0000899243-21-014831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1665988/000089924321014831/doc4.xml","form_type":"4"}}]}